ID 7.6.50600 Mogrify - Cell reprogramming to engineer scalable cell therapies and tools

Platform using transcriptional network analysis to convert cell types for therapy and research.

Mogrify builds a platform for direct cell reprogramming by identifying transcription factors and culture conditions that convert one cell type into another. This approach aims to generate functional cell types for therapies and research tools without stem cell intermediates. The company partners with academic and industry groups to progress programs toward the clinic. Computational biology, wet lab validation and manufacturing know how combine to move candidates forward. The objective is scalable, reproducible processes that broaden access to advanced cell therapies.

Organization

Listed as: Brand page

Brand:

Mogrify

Country:

GB

Official page
  • Category: 7. Healthcare & Life Sciences
  • Subcategory: 7.6 Biotech
  • Technology: Transcription factor mapping. Network analysis. Direct reprogramming. GMP processes.
  • Release Date:
  • Canonical Url: